ELV Elevance Health, Inc. - Fundamental Analysis
NEUTRAL
ELV Stock | Fundamental Analysis & Investment Insights
NYSE
•
Healthcare
•
Healthcare Plans
Current Price
$354.25
Analyst Target
$389.21
+9.9% Upside
52W High
$458.75
52W Low
$273.71
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
72%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a mixed picture: the Piotroski F-Score of 3/9 indicates weak financial health, while the Altman Z-Score of 319992492441.6 suggests an extremely low distress risk, implying strong balance sheet resilience. Despite solid revenue and earnings growth, declining recent EPS trends and a bearish technical score weigh on momentum. The stock trades below the analyst target of $389.21 but above the conservative Graham Number of $330.67, indicating modest undervaluation with structural concerns. Dividend sustainability is supported by a low payout ratio, though insider sentiment is neutral and recent performance has lagged peers.
Key Strengths
Exceptionally high Altman Z-Score indicates near-zero bankruptcy risk and robust financial stability
Strong year-over-year earnings growth of 22.0% and revenue growth of 12.30% demonstrate operational momentum
Low P/E of 14.43 and Forward P/E of 13.19 compared to sector average of 280.28 suggest significant valuation discount
Healthy return metrics including ROE of 12.57% and ROA of 4.24% outperform sector averages on efficiency
Dividend payout ratio of 27.55% is sustainable with room for future increases
Key Risks
Piotroski F-Score of 3/9 signals weak financial health, particularly concerning profitability and earnings consistency
Most recent Q/Q EPS growth of -21.9% and YoY EPS decline of -28.0% indicate deteriorating earnings momentum
Technical Trend score of 0/100 reflects strong bearish price action, suggesting negative market sentiment
Limited visibility due to missing key data points (e.g., EV, cash, debt, shares outstanding) raises transparency concerns
Only 2 out of last 4 quarters beat estimates, with recent misses indicating weakening execution
AI Fair Value Estimate
Based on comprehensive analysis
$365.0
+3.0% above current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ELV against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations